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During development in the thymus, invariant natural killer T (iNKT) cells commit to one of
three major functionally different subsets, iNKT1, iNKT2, and iNKT17. Here, we show that T
cell antigen receptor (TCR) signal strength governs the development of iNKT cell subsets,
with strong signaling promoting iNKT2 and iNKT17 development. Altering TCR diversity or
signaling diminishes iNKT2 and iNKT17 cell subset development in a cell-intrinsic manner.
Decreased TCR signaling affects the persistence of Egr2 expression and the upregulation of
PLZF. By genome-wide comparison of chromatin accessibility, we identify a subset of iNKT2-
specific regulatory elements containing NFAT and Egr binding motifs that is less accessible in
iNKT2 cells that develop from reduced TCR signaling. These data suggest that variable TCR
signaling modulates regulatory element activity at NFAT and Egr binding sites exerting a
determinative influence on the dynamics of gene enhancer accessibility and the develop-
mental fate of iNKT cells.
DOI: 10.1038/s41467-018-05026-6 OPEN
1 Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 E. 19th Ave, Aurora, CO 80045, USA.
2Department of Biomedical Research, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA. 3 Center for Genes, Environment, and Health,
Department of Biomedical Research, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA. 4Department of Pediatrics, National Jewish
Health, 1400 Jackson Street, Denver 80206 CO, USA. 5 RNA Bioscience Initiative, University of Colorado School of Medicine, 12800 E. 19th Ave, Aurora
80045 CO, USA. 6 Department of Biochemistry & Molecular Genetics, University of Colorado School of Medicine, 12800 E. 19th Ave, Aurora, CO 80045,
USA. 7 La Jolla Institute, 9420 Athena Cir, La Jolla 92037 CA, USA. 8 Sanford Consortium for Regenerative Medicine, 2880 Torrey Pines Scenic Dr, La Jolla,
CA 92037, USA. 9University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA. 10 Department of Medicine, University of Colorado
Anschutz Medical Campus, 12800 E. 19th Ave, Aurora, CO 80045, USA. 11Present address: Department of Oncology, University of Lausanne, Chemin des
Boveresses 155, Epalinges 1066, Switzerland. 12Present address: ARUP Laboratories, Institute of Clinical and Experimental Pathology, 500 Chipeta Way, Salt
Lake City 84108, UT, Switzerland. 13Present address: Department of Pathology, University of Utah, 30N 1900E, Salt Lake City 84132, UT, USA. 14Present
address: Merck Research Laboratories, San Francisco, CA, USA. These authors contributed equally: Kathryn D. Tuttle, S. Harsha Krovi. Correspondence and
requests for materials should be addressed to L.G. (email: Laurent.Gapin@ucdenver.edu)









iNKT cells recognize lipid antigens presented by CD1d, a non-polymorphic major histocompatibility complex (MHC) classI-like antigen-presenting molecule1. These cells use a semi-
invariant TCR made up mostly of a single invariant TCRα chain
(Vα14-Jα18 in mice, Vα24-Jα18 in humans) with certain TCRβ
chains (Vβ8.2, Vβ7, or Vβ2 in mice, Vβ11 in humans) to engage
CD1d. In the thymus, iNKT cells develop into three major
terminally differentiated and functionally distinct iNKT cell
subsets2,3. iNKT1 cells express the transcription factor T-bet and
secrete predominantly IFNγ; iNKT2 cells express high levels of
the GATA3 and promyelocytic leukaemia zinc finger (PLZF)
transcription factors and secrete IL-4 and IL-13; iNKT17 have
intermediate levels of PLZF, are positive for RAR-related orphan
receptor gamma (Rorγt) expression, and secrete IL-17. Impor-
tantly, the relative distribution of the three thymic iNKT subsets
varies in different mouse strains and affects the phenotype and
activation status of surrounding cells.
Unlike most T cells that leave the thymus to populate the
peripheral immune organs, some mature iNKT cells are retained
in the thymus and become long-term thymic residents4, with
potentially important functions. In particular, mature thymic
iNKT2 cells produce IL-4 at steady state and thus affect the
homeostasis of thymic cell populations2. Indeed, IL-4 conditions
CD8+ T cells to become “memory-like” and to express the
transcription factor Eomesodermin5. These CD8 “memory-like”
T cells have important roles in early defenses, particularly
in situations of chronic viral infection6,7. Thymic steady-state IL-
4 also drives the acquisition of an activated/memory-like phe-
notype by Foxp3+ regulatory T cells8, the production of che-
mokines by thymic dendritic cells2, the thymic exit of mature
“conventional” T cells9 and also perhaps the commitment of early
thymic progenitors to the T cell lineage10. Additionally, RANKL-
expressing CD44− thymic iNKT cells (which are preferentially
enriched for iNKT2 and iNKT17 cells) regulate the differentiation
of Aire+ MHC class II+ medullary thymic epithelial cells11 that
are involved in clonal deletion of self-reactive T cells12 and Treg
maturation13. Altogether, these results suggest that thymic
iNKT cells, and particularly the relative subset representation,
have fundamental roles in the composition of other thymic cell
populations, both by modulating homeostasis and maturation
status of these cells, and potentially in shaping the overall size and
repertoire diversity of mature “conventional” T cells.
Development of iNKT cells diverges from that of conventional
T cells primarily at the double-positive CD4+ CD8+ (DP) stage
and requires TCR recognition of CD1d on DP cells, involving
homotypic interactions across a DP–DP synapse where second
signals are initiated by the engagement of homophilic receptors of
the signaling lymphocytic-activation molecule (SLAM) family,
Slamf1 (SLAM) and Slamf6 (Ly108). This signaling recruits the
adaptor SLAM-associated protein (SAP) and the Src kinase Fyn,
both of which are essential for the development of the iNKT cell
lineage3. The TCR signals received by iNKT cell precursors
during selection are associated with high expression of the Ras-14
and Ca2+-dependent transcription factors Egr1 and, especially,
Egr215,16. Interestingly, high expression levels of Egr2 in pre-
selection DP thymocytes are potentiated by co-stimulation
through Ly10817,18. Egr2 directly regulates the expression of
several genes involved in the development of iNKT cells,
including PLZF and CD122, one of the chains of the IL-15
receptor15. Egr2 is recruited to the promoter of Zbtb16 (which
encodes PLZF) after TCR engagement and co-stimulation with
Ly10815,17. PLZF directs the acquisition of effector properties,
such as the upregulation of CD44 and production of effector
cytokines19,20. Expression of PLZF directs the acquisition of
effector properties by binding and regulating T helper-specific
transcription factor genes that in turn control T-helper-specific
programs19–21. Several transcription factors and signaling mole-
cules affect the lineage diversification of iNKT cell subsets. On the
whole, however, the mechanisms that control these iNKT cell fate
decisions during development remain poorly understood.
Here, we show that TCR signal strength governs the develop-
ment of iNKT cell subsets in the thymus, with high sig-
nal strength being necessary for iNKT2 and iNKT17
development. The avidity of the iNKT TCR–CD1d interaction
correlates with iNKT cell subset assignment and the expression of
markers reflecting strength of signaling during selection, sug-
gesting that differential TCR signal strength likely has a role in
iNKT cell subset differentiation. Limiting the iNKT TCR reper-
toire diversity through the use of TCRβ transgenic mice and/or
TCR signaling using mice with Zap70 mutations markedly
impacts iNKT2 and iNKT17 cell subset development in a cell-
intrinsic manner. Decreased TCR signaling affects the longevity
of Egr2 expression and the upregulation of PLZF both in vitro
and in vivo. Genome-wide chromatin accessibility analysis reveals
subset-specific activity of regulatory elements associated with
unique transcription factor binding site signatures. NFAT and
Egr binding motifs are found preferentially enriched in chromatin
regulatory regions specifically accessible in iNKT2 cells that are
not accessible in iNKT2 cells that had developed with reduced
TCR signaling. Altogether, these data suggest a model of iNKT
cell subset development wherein variable TCR signaling induces
changes in chromatin accessibility at NFAT and Egr binding sites
that exert a determinative influence on the dynamics of gene
enhancer accessibility that in turn determines the developmental
fate of iNKT cells.
Results
Characteristics of thymic iNKT cell subsets. We analyzed thy-
mic iNKT cells from BALB/c mice in which the human CD2 gene
was knocked-in into the IL-4 locus (KN2), thereby allowing for
the identification by flow cytometry of IL-4-secreting iNKT2 cells
directly ex vivo. iNKT cells, identified using PBS57–CD1d tetra-
mer and TCRβ co-staining, were electronically placed on a grid
consisting of 30 gates, allowing for the analysis of iNKT cells
expressing different TCR levels and/or different binding to the
PBS57–CD1d tetramer for a given level of TCR (Fig. 1a). Thus,
each gate examined cells with different avidities for the
antigen–CD1d complex. The proportion of each iNKT subset in
each of the 30 different gates was calculated (Supplementary
Fig 1) and displayed as a heatmap. Although not all gates contain
the same number of cells, displaying the proportion of each iNKT
cell subsets in the 30 gates revealed a direct correlation between
the overall avidity of the TCR–PBS57–CD1d interaction and the
three major iNKT cell subset phenotypes (Fig. 1b). iNKT1 cells
express the lowest amount of TCR and are stained by the tetra-
mer with the lowest intensity. iNKT17 cells express intermediate
levels of TCR. However, for a given level of TCR expression,
iNKT17 cells bind the tetramer more strongly than iNKT1 cells.
Finally, iNKT2 cells express the highest TCR levels and stained
more brightly with the PBS57–CD1d tetramer. This correlation is
not observed with another marker of mature iNKT cells (CD44).
These results demonstrate that the different thymic iNKT cell
subsets have disparate but overlapping avidities for the
PBS57–CD1d complex.
It is conceivable that these observed differences in avidities for
the CD1d-foreign antigen PBS57 could also reflect differential
avidities for the CD1d-self antigen(s) recognized during positive
selection of the different iNKT cell subsets. Consequently, the
strength of TCR signaling received by the different iNKT cell
subsets during positive selection might be different as well.
Surface expression of CD5 and CD6 molecules directly parallels
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the signaling intensity of the positively selecting
TCR–MHC–ligand interaction22–26, while expression of Ly6C
by CD4 T cells is inversely correlated with self-reactivity of their
TCRs27. As seen in Fig. 1c, iNKT2 cells express the highest level
of CD5 and CD6 proteins while they are negative for Ly6C.
iNKT17 cells have lower levels of CD5 and CD6 expression than
iNKT2 cells and are also Ly6C negative. Finally, iNKT1 cells
express the lowest levels of CD5 and CD6 proteins of the three
subsets, while >60% of the cells are also Ly6C positive. Thus, on
the basis of expression of these 3 markers, it appears that the
three iNKT cell subsets have received different strengths of
signaling during selection in the thymus, with the following
hierarchy iNKT2 > iNKT17 > iNKT1. We also examined Egr2
expression in the three iNKT cell subsets (Fig. 1c). The results
show that iNKT2 cells express the highest level of Egr2 followed
by iNKT17 and iNKT1 cells. These results are in agreement with
the expression of GFP driven from the immediate early gene
Nr4a1 (Nur77) locus, which directly correlates with the strength
of TCR stimulus28. Altogether, these results demonstrate that the
different iNKT cell subsets receive signals of different strength
during their development in the thymus and that the avidity of
the TCR repertoires expressed by each subset positively correlates
with this signaling strength.
Development of iNKT subsets in mice with a fixed TCRβ chain.
We examined whether the development of iNKT cell subsets
would be disturbed if the specificity of the repertoire was fixed.
We used transgenic mice that express the TCRβ chain derived
from the OVA-IAd-specific clone DO-11.10 (DO). The compo-
sition of iNKT cell subsets in the thymus of 8-week-old B6 and
BALB/c mice is different with BALB/c mice having large popu-
lations of iNKT2 and iNKT17 cells compared to B6 mice (Fig. 2)2.
Interestingly, the B6 × BALB/c F1 strain recapitulates the BALB/c
phenotype (Fig. 2), allowing us to analyze the effect of TCRβ DO
expression on iNKT cell subset development in B6 mice and F1
(B6 × BALB/c) mice. Enforced expression of a single TCRβ chain
strongly affects the development of iNKT cell subsets on both
genetic backgrounds (Fig. 2). The proportions of iNKT2 and
iNKT17 cells in DO11.10 TCRβ transgenic mice are largely
reduced compared to those of control mice with polyclonal
repertoires, demonstrating that the specificity of the iNKT TCR
has a key role in the development of iNKT cell subsets.
Vβ repertoire and Egr2 levels in thymic iNKT cell subsets. In
addition to its surface expression level, the nature of the TCR
itself can affect the duration and the strength of TCR signaling29.
Therefore, we assessed the percentage of Vβ usage for the three
iNKT cell subsets expressing different avidities for the
PBS57–CD1d tetramer. BALB/c thymic iNKT cells were electro-
nically gated based on three discrete TCR levels (Fig. 3a).
Although the correlation between avidity and iNKT cell subsets
held generally true (Fig. 1a), each iNKT subset could nevertheless
be found, albeit in very low frequencies in some instances, for
each level of TCR expression (Fig. 3a). We examined the
expression of Vβ2, Vβ7, Vβ8.1/8.2, and Vβ8.3 by the three iNKT
cell subsets found for each level of TCR (Fig. 3b). In agreement
with previous results2, we found that the proportion of Vβ usage
is different between iNKT cells subsets. Unexpectedly, however,
the proportion of Vβ usage within a given subset also varies
between cells having different avidities for the PBS57–CD1d
complex. For example, 52% of iNKT17 cells expressing low TCR
levels use the gene segment Vβ8.3, while only 5.1% of iNKT17
cells that are TCRhi are Vβ8.3+ (Fig. 3b). Likewise, 19% of TCRlo
iNKT2 cells use Vβ8.1/8.2 but this proportion increased to 55%
for iNKT2 cells expressing high levels of TCRs (Fig. 3b). These
results demonstrate that the repertoire of each iNKT cell subset is
not only unique to a given subset but also varies as a function of
the level of TCR surface expression. We also analyzed the levels of
Egr2 expression in each iNKT subset expressing different TCR
levels. Each iNKT cell subset expresses a limited range of Egr2
protein (Fig. 3c, d) that appears delimited by the levels of TCR
surface expression for a given subset. For example, the few
iNKT1 cells that are TCRhi express Egr2 levels that remain lower





















































Fig. 1 Thymic iNKT subsets have different avidities for the PBS57–CD1d tetramer that correlate with expression of surrogate markers reflective of strength
of signaling during selection. a Cells from the thymus of BALB/c IL-4 reporter KN2 mice were stained with anti-TCRβ mAbs and PBS57–CD1d tetramers.
iNKT cells were then electronically placed on a grid consisting of 30 gates, allowing for the analysis of iNKT cells expressing different TCR levels and/or
different binding to the PBS57–CD1d tetramer for a given level of TCR. b The proportion of iNKT1 (PLZFlo, Rorγt−, Tbet+), iNKT17 (PLZFint, Rorγt+, Tbet−),
iNKT2 (PLZFhi, Rorγt–, Tbet–, or hCD2+) as well as the proportion of CD44hi cells in each gate was recorded and displayed as a heatmap. c Representative
histograms for the expression of CD5, CD6, Ly6C, and Egr2 in each iNKT cell subset (as defined by the gating strategy shown on the left) is shown. Data
are representative of n > 3 mice for each staining
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cell subset expresses a unique TCRβ repertoire modulated by the
overall level of TCR expression on the cells but that the combi-
nation results in discrete signal strength.
Thymic iNKT cell subsets in Zap70-mutant mice. To fur-
ther test the idea that strength of TCR signaling affects iNKT cell
fate choice, we examined iNKT cell development in mouse
models with hypo-responsiveness to TCR stimulation, the YYAA
and SKG mice30,31. Both mutations diminish TCR signal strength
and thus provide opportunities to analyze the effects of signal
strength on iNKT cell differentiation on both B6 and BALB/c
genetic backgrounds. Both strains show skewed development of
iNKT subsets (Fig. 4). In the thymus of YYAA mice, iNKT2 cells
are largely decreased proportionally and numerically compared to
the B6 controls (Fig. 4a, b), while in SKG mice, which have a
more profound impairment of TCR signaling than the YYAA
mice30, most of the iNKT cells are iNKT1 cells in striking contrast
to those in age-matched control BALB/c mice (Fig. 4a, c). Because
differences in subset ratios are stronger between BALB/c and SKG
mice, subsequent experiments are only carried out with these two
strains.
Cell-intrinsic Zap70 affects iNKT subset development. To
determine whether the SKG mutation effects on iNKT cell subset
development are cell intrinsic or extrinsic, we generated compe-
titive bone marrow chimeras. BALB/c-derived bone marrow cells
produce all three iNKT cell subsets with large proportions of
iNKT2 (40–50%) and iNKT17 (5–6%) cells (Fig. 4d). By contrast,
SKG-derived iNKT cells are composed mostly of iNKT1 cells,
with poor representation of iNKT2 (4%) and iNKT17 (0.3%)
cells. These results demonstrate that iNKT cell precursors need to
receive adequate TCR signaling mediated through Zap70 in order
to develop efficiently into the iNKT2 and iNKT17 lineages and
that cell extrinsic signals in the thymus cannot compensate for
this deficiency.
Zap70 activity-dependent gene expression in stage 0 cells. To
determine whether changes in strength of TCR signaling might
have affected the developmental program of iNKT cells, we used
RNA-Seq to compare gene expression in the earliest iNKT cell
progenitors, just after positive selection (stage 0 cells), between
BALB/c and SKG mice. iNKT cells were enriched using
PBS57–CD1d tetramer and magnetic beads (Fig. 5a). Stage 0
iNKT cells were defined as CD44lo, CD24+, CD4low/−, CD8−,
CD69+, and sorted using these markers. This sorting strategy
eliminates DP thymocytes that invariably contaminate the
CD24+ fraction and that do not represent genuine stage 0
iNKT cells that are actively signaling (Fig. 5a and Supplementary
Fig 2). Confirmation that these cells are genuine iNKT precursors
is provided by the analysis of the sequencing reads that are
mapped to the TCRα locus (Supplementary Fig 3). We detected
statistically significant differential expression (FDR < 0.1) of 238
genes between the two genotypes (Fig. 5b), with a significant
enrichment for genes implicated in cell activation and immune
cell development (Supplementary Fig 4). Amongst the differen-
tially regulated genes, several are known regulators of iNKT cell
development, including Egr1 and Egr2, Myc, Tcf7, Klf2, Runx3,
and RORa. Interestingly, several factors involved in chromatin
remodeling and transcriptional regulation, which are induced
during positive selection of T lymphocytes (Patz1 and Satb1), are
also differentially regulated. Altogether, these results demonstrate
C57BL/6 C57BL/6
DOβ Tg
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Fig. 2 Development of iNKT cell subsets in DO11.10 TCRβ transgenic mice on the C57BL/6 or C57BL/6 × BALB/c F1 background. a The thymi of 8-week-
old C57BL/6, C57BL/6 DO11.10 TCRβ transgenic, BALB/c, C57BL/6 × BALB/c F1, and BALB/c × C57BL/6 DO11.10 TCRβ transgenic mice were stained
with anti-CD24 mAbs, PBS57–CD1d tetramers and mAbs specific for the transcription factors PLZF, Rorγt, and Tbet. Representative flow cytometry plots
for the frequency of total mature iNKT cells and iNKT subsets in each genotype is shown. b Summary of the data shown in a with three mice per group.
Data are mean ± SD. Significance was assessed using multiple comparison one-way analysis of variance (ANOVA) *p < 0.05; **p < 0.01; ***p < 0.001;
****p < 0.0001; ns, not significant. For clarity purposes, the only statistics shown are between mice with or without expression of the DO11.10 TCR
transgene for a given genetic background
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that TCR hypo-responsiveness affects iNKT cell development
even at the earliest stage of commitment.
Reduced Egr2 expression in iNKT cells from SKG mice. In
agreement with the RNA-seq data, the levels of Egr2 in stage 0
iNKT cells of SKG mice (gMFI 4866 ± 421) are slightly reduced
(10%) compared to those in BALB/c animals (gMFI 5432 ± 293),
although the results do not reach statistical significance (Fig. 5d).
According to the conventional “staging” system of iNKT cell
development3, immediately following stage 0, precursor cells
(iNKTp) are CD44lo CD24− CD69− and PLZFhi 2. The cells
subsequently reach stage 2 (CD44hi), which contains functionally
mature iNKT cell subsets3. We observed that the differences in
the levels of Egr2 expression between BALB/c and SKG mice are
more pronounced as the cells progress in their maturation
(Fig. 5c, d). iNKTp cells from SKG mice express 1/3 less Egr2
than their counterpart cells in wild-type mice (Fig. 5d). While
iNKT2 cells express the highest levels of Egr2 of the three iNKT
subsets in BALB/c mice (Figs. 1 and 5d), its level of expression in
the few iNKT2 cells of SKG mice (gMFI 469 ± 35) is comparable
to the levels found in BALB/c iNKT1 cells (gMFI 459 ± 15).
Expression of PLZF and Rorγt in iNKT2 and iNKT17 cells
respectively, are also lower in SKG mice (Fig. 5d). Altogether,
these results demonstrate that during development of iNKT cells
in SKG mice, Egr2 is induced at near normal levels in stage 0
iNKT cells but its expression is not sustained effectively as the
cells mature.
Modulation of Egr2 and PLZF induction in vitro. While
induction of Egr2 expression in developing T cells is known to
occur downstream of TCR signaling, whether PLZF is induced in
an Egr2-dependent manner in response to TCR signaling has
been controversial15,32. Pre-selection DP thymocytes from the
thymus of BALB/c and SKG mice were stimulated with anti-CD3,
anti-Ly108 or a combination of both, and followed over time for
the expression of Egr2 and PLZF. As seen in Fig. 6, TCR sti-
mulation alone of BALB/c DP thymocytes triggers a few cells to
produce Egr2 but its level of expression, which peaks around 40 h
post stimulation, remains low. In these conditions, we do not
detect PLZF expression at any time point post stimulation. As
reported previously17,18, co-stimulation with the SLAM family
member Ly108 increases the proportion of cells expressing Egr2
as well as the level of expression per cell. Interestingly,
cells expressing the highest levels of Egr2 begin to express the
PLZF protein around 32 h post stimulation with the proportion of
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Fig. 3 Thymic iNKT subsets with different TCR levels express different proportions of Vβ usage but discrete Egr2 levels. Cells from the thymus of 8-week-
old BALB/c mice were stained with anti-TCRβ mAbs, PBS57–CD1d tetramers, mAbs specific for the transcription factors PLZF, Rorγt, and Tbet and the
indicated anti-Vβ mAbs. a iNKT cells were subdivided based on expression of different TCR levels. The proportion of iNKT cell subsets for each level of
TCR expression (TCRlow (blue), TCRint (orange) and TCRhigh (green)) is shown. b The percentage of Vβ usage found in each iNKT subset expressing three
distinct TCR levels is shown with the fluorescence minus one control (FMO). Data are representative of three independent mice analyzed. c Example of
Egr2 expression in each iNKT cell subsets expressing different levels of TCR. d The gMFI of Egr2 expression was recorded from three independent staining
of iNKT cell subsets expressing different TCR levels from one individual mouse as gated in a. Three independent mice were analyzed in this way with
similar results
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05026-6 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:2650 | DOI: 10.1038/s41467-018-05026-6 | www.nature.com/naturecommunications 5
establish that the transcription factor PLZF can be induced in DP
thymocytes following TCR/Ly108 stimulation and that only the
cells that sustain the highest levels of Egr2 can also express PLZF.
Stimulation of SKG DP cells in the same conditions induces a
slightly lower percentage of Egr2+ cells than the BALB/c cells
(Fig. 6b, c) but the levels of Egr2 induced never reach the levels
found in the BALB/c cells at any time point post stimulation, and
few PLZF+ cells are detected in these conditions. These results
recapitulate ex vivo observations (Fig. 5) and further support the
hypothesis that modulation of TCR signal strength can affect
iNKT cell subset differentiation, in part by modulating expression
of Egr2 and PLZF.
Zap70 activity affects chromatin landscape of iNKT subsets. To
assess how TCR signal strength might influence lineage differ-
entiation via regulatory elements, we compared chromatin
accessibility between BALB/c and SKG iNKT1 and iNKT2 cells
with ATAC sequencing (ATAC-seq). iNKT1 and iNKT2 cell
subsets show a unique chromatin landscape, with regions of
accessibility specific to each subset. In agreement with their dis-
tinct functionalities, the accessibility of subset signature genes
(Ifnγ, Tbx21, Cxcr3, Ccr5, Il2rb, Fasl, Bcl2, Il2, Zbtb16, Slamf6,
Il17rb, Il6ra, Ccr7) is different between subsets (Supplementary
Figs. 5 and 6). For example, the chromatin landscapes of the Ifnγ
and Tbx21 genes, encompassing not only their promoters but also
intragenic and intergenic regions extending as far as several
kilobases away, are clearly accessible in iNKT1 but not in iNKT2
cells. By contrast, the chromatin landscape surrounding the
Zbtb16 (encoding PLZF), Slamf6 (encoding Ly108), Il17rb, Il6ra,
and Ccr7 genes is clearly more accessible in iNKT2 than
iNKT1 cells, in agreement with the differential expression of these
genes between these two iNKT subsets33–35. Globally, 17,464
regions (out of a total of 90,051 accessible regulatory regions
identified) are differentially accessible between BALB/c iNKT1
and iNKT2 cells (Fig. 7a). Similarly, 11,065 regions are differen-
tially accessible between SKG iNKT1 and iNKT2 cells (Fig. 7c).
Regions that are more accessible in BALB/c iNKT1 than in
BALB/c iNKT2 cells also tend to be more accessible in SKG
iNKT1 than in SKG iNKT2 cells (Fig. 7b, d). Conversely, the
same holds true for regions that are more accessible in iNKT2
over iNKT1 cells (Fig. 7b, d). These results suggest that the
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Fig. 4 Cell-intrinsic deficiency in iNKT2 and iNKT17 subsets development in mice with Zap70 hypomorphic mutations. a Representative flow cytometry
plots showing the frequency of total iNKT cells and iNKT cell subsets in the thymi of 8-week-old C57BL/6, C57BL/6 YYAA, BALB/c, and BALB/c SKG
mice. Each genotype was analyzed independently and compared to wild-type control mice of the appropriate background. b, c Summary of the data shown
in a with percentages and cell numbers of total iNKT cells and iNKT cell subsets in the various genotypes analyzed. Data are mean ± SD. Significance was
assessed using the unpaired t-test. d Analysis of thymic iNKT cell subsets in competitive bone marrow chimera. Congenically marked bone marrow cells
from BALB/c wild-type mice (CD45.1) were mixed in a 1:1 ratio with (CD45.2) BALB/c or SKG bone marrow cells and injected into lethally irradiated F1
(CD45.2 × CD45.1) BALB/c mice. The thymi of the chimera were analyzed for iNKT cell subset composition 8–10 weeks post reconstitution and
representative flow cytometry plots are shown. After gating on total iNKT cells, the proportion of iNKT cell subsets derived from either CD45.2+ or CD45.1
+ bone marrow cells is shown. e Summary of the data shown in d with ≥5 mice per group. Data are represented as mean ± SD. Significance was assessed
using one-way analysis of variance (ANOVA) *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; ns, not significant
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landscape specific to each iNKT cell subset are conserved between
BALB/c and SKG mice. To ask whether there are specific changes
in chromatin accessibility in iNKT cells from SKG mice, we
compared the ATAC-seq data between BALB/c and SKG back-
grounds for each subsets. In iNKT1 cells, we identified 267
regions that are differentially accessible between BALB/c and
SKG, suggesting that reduced TCR signaling only minimally
impacts the differentiation of the iNKT1 lineage (Fig. 7e). By
comparison, 4254 regions are differentially accessible between
BALB/c and SKG iNKT2 cells (Fig. 7e), with >75% of these
regions only accessible in BALB/c cells with reduced accessibility
in SKGs. To group regulatory elements with similar profiles on
their relative signal in each subsets between BALB/c and SKG
mice, we partitioned all differentially accessible regions into 6
clusters using k-means. Regions in clusters 1, 4, and 5 define the
iNKT1 chromatin landscape signature and are significantly
enriched for T-box, Runt, and ETS binding sequences, while
clusters 6 and 3 are associated with iNKT2 cells and are enriched
for Tcf, Rorγt, NFκB, Egr and NFAT-binding sites (Fig. 7f).
Interestingly, cluster 3, which defines peaks found in BALB/c
iNKT2 cells but absent from SKG iNKT2 cells, is strongly enri-
ched for NFAT and Egr binding sites (Fig. 7b), suggesting that
this unique signature is affected by the SKG mutation (Fig. 7b).
Conversely, cluster 2, which defines peaks found in SKG
iNKT cells but absent from BALB/c iNKT cells, shows an
enrichment for NFκB-binding sites (Fig. 7f). These results suggest
that in addition to losing the NFAT/Egr signature, potentially due
to a quantitative decrease in TCR signaling, the SKG mutation
also alters the signal received by the cells in a qualitative manner.
PD1 expression in activated CD8 T cells is controlled by
regulatory regions in the Pdcd1 locus. Accessibility to these
regions has been directly linked to the binding of NFAT36,37. The
same regulatory regions are found accessible in BALB/c
iNKT cells (Fig. 7g), with small differences between BALB/c
iNKT1 and iNKT2 cells, suggesting that the locus might be
differentially regulated in these subsets (Fig. 7g). Importantly
however, accessibility to these sites is largely diminished in both
iNKT subsets derived from SKG mice (Fig. 7g). Consequently,
PD1 is poorly expressed on SKG iNKT cells compared to the
wild-type cells (Fig. 7h). These results illustrate the loss of the
NFAT signature in iNKT cells from the SKG mice (Fig. 7f).
While the chromatin accessibility profile of the Zbtb16 locus
(encoding PLZF) is not disturbed by the SKG mutation in any
iNKT subset (Supplementary Fig 6), we noticed that the loci
surrounding two of the transcription factors known to regulate
the expression of PLZF in iNKT cells (Egr2 and Runx115,38) are
affected (Fig. 7i, j). Within 50 Kb of the Egr2 transcription start,
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Fig. 5 Differential gene expression in iNKT cells of BALB/c and SKG mice. a Gating strategy used to identify and sort stage 0 iNKT cells in BALB/c (top)
and SKG (bottom) mice. Enrichment of iNKT cells from the thymi of BALB/c or SKG mice was achieved after staining with APC-labeled PBS57–CD1d
tetramer and enrichment using anti-APC magnetic beads. Stage 0 iNKT cells were defined as TCRβ+ PBS57–CD1d tetramer+ CD44− CD24+ CD4lo CD8−
CD69+. As seen on the figure, these cells are also Egr2+ (red) in contrast with the CD4+CD8+ (blue) population that invariably contaminates the cell
preparation. b Mean average plot of genes expressed differentially in stage 0 iNKT cells isolated from SKG mice relative to their expression in such cells
from BALB/c control mice. Data are representative of one experiment with three biological replicates per genotype. 238 genes (displayed in black) were
found to be differentially expressed >1.5-fold with a false discovery rate <0.1. c Analysis of transcription factor (PLZF, Rorγt, and Tbet) expression in stage 1
(CD44− CD24−) and stage 2 (CD44+) iNKT cells from the thymi of BALB/c and SKG mice. Data are representative of >5 mice analyzed for each
genotype. d Analysis of Egr2 expression level in BALB/c (orange) and SKG (purple) iNKT cells at different developmental stages. Results from three mice
of each genotypes analyzed independently are shown. The mean ± SD of Egr2 gMFI in each iNKT cell developmental stage in BALB/c and SKG mice is
shown. Significance was assessed using the unpaired t-test. **p < 0.01; ***p < 0.001; ****p < 0.0001; ns, not significant
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shown to directly bind NFAT in CD8 T cells (Fig. 7i).
Importantly, accessibility to these five regions is different between
BALB/c iNKT1 and iNKT2 cells, suggesting that control of Egr2
expression between iNKT cell subsets involves different regula-
tory mechanisms. Nevertheless, for both iNKT subsets, the SKG
mutation affects the pattern of chromatin accessibility of putative
Egr2 regulatory regions (Fig. 7i). These results are consistent with
the diminished levels of Egr2 expression within these cells
(Fig. 5d). Similar results are found for the Runx1 locus, where
subset-specific chromatin accessibility peaks can clearly be
delineated (Fig. 7j). Two of these regulatory regions (one of
them directly binds NFAT in CD8 T cells) are affected by the
SKG mutation (Fig. 7j), suggesting that like Egr2, Runx1
expression might also have been disturbed by the SKG mutation.
Finally, analysis of the transcription starting site (TSS) of the Klf2
gene demonstrates more accessibility in BALB/c iNKT1 over
iNKT2 cells, in agreement with the known differential expression
of this gene between iNKT1 and iNKT2 cells2,35. Accessibility at
the TSS is largely increased in both iNKT subsets derived from
the SKG mice (Fig. 7k). Such increase in Klf2 expression is
already apparent in stage 0 SKG iNKT cells (Fig. 5b).
To identify potential gene targets of the regulatory elements
that are differentially accessible between BALB/c and SKG
iNKT cells, we performed gene ontology analysis using GREAT
(Genomic Regions Enrichment of Annotation Tool)39 (Supple-
mentary Fig 7). For cluster 3, we observe a significant enrichment
of gene onthology (GO) terms for the regulation of kinase activity
and Notch signaling (Supplementary Fig 7 and Supplementary
Table I). Several genes encoding proteins involved in the
regulation of mitogen-activated protein kinases (MAPK) activity,
including the dual-specificity protein phosphatases Dusp4,
Dusp5, and Dusp640, as well as the MAPK/Erk pathway
regulators sprouty proteins 1 and 241 show differential chromatin
accessibility profiles between iNKT cell subsets that are affected
by the SKG mutation (Supplementary Fig. 8). Similar observa-
tions are made for the Notch pathway-associated genes, Hey1,
Jag1, Ovol2, and Rbpj (Supplementary Fig 9). Interestingly, several
of these peaks (but not all) bind NFAT in CD8 T cells
(Supplementary Figs. 8 and 9). Altogether, these results suggest
a potential link between the reduced TCR signaling in SKG mice
and alterations of MAPK/Erk activity and Notch signaling in
having a role in the development of iNKT cell subsets.
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Fig. 6 Induction of Egr2 and PLZF in pre-selection DP thymocytes stimulated with plate-bound anti-CD3 and anti-Ly108 mAbs is affected by the SKG
mutation. a Expression of Egr2 and PLZF proteins in pre-selection BALB/c or SKG DP thymocytes stimulated with media alone (no stim), plate-bound anti-
CD3, anti-Ly108, or anti-CD3+ anti-Ly108 for 48 h. At the end of the stimulation, cells were stained using anti-CD4, -CD8, -Egr2, -PLZF mAbs, and a
viability dye. The percentages of live cells that are Egr2+ and PLZF+ are indicated for each stimulatory condition. b Time course of CD4, CD8, Egr2, and
PLZF expression in pre-selection BALB/c or SKG DP thymocytes stimulated with plate-bound anti-CD3+ anti-Ly108 mAbs. Data are shown for live cells in
each conditions. c Summary of the data shown in b for each stimulatory condition. The percentage of Egr2+ cells, the gMFI of Egr2 expression, and the
percentage of PLZF+ cells are shown. Each experimental condition was tested in duplicate wells and the data are representative of greater than three
independent experiments with similar results
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05026-6
8 NATURE COMMUNICATIONS |  (2018) 9:2650 | DOI: 10.1038/s41467-018-05026-6 | www.nature.com/naturecommunications
Discussion
In the thymus, T cell precursors are selected to undergo different
fates and functions such as becoming γδ or αβ T cells42, CD4 or
CD8 T cells43, positively selected or clonally deleted44, and
“conventional” or “agonist-selected” lymphocytes45. In these
processes, TCR signals cooperate with co-stimulatory molecules,
cytokines, chemokines, integrins, and metabolic signals to reg-
ulate the generation of T cells with very different phenotypes and
functions.
Here, we demonstrate that TCR signal strength is an essential
variable in shaping the development of iNKT cell subsets. The
three major thymic iNKT subsets generally have different avid-
ities (a combination of TCR expression levels and TCR affinities)
for the PBS57–CD1d complex, which is correlated with different
levels of proteins whose surface expression levels reflect the TCR
signal strength initially perceived during selection22,26–28. Thus,
as reported previously for conventional T cells23,25, the strength
of self-reactivity appears directly related to the strength of TCR
binding to the α-galactosylceramide analog (PBS57) presented by
CD1d. Interestingly, αGC was recently identified in the mouse
thymus where it was proposed to have a role in the positive
selection of iNKT cells46. iNKT2 cells stain the brightest with the
PBS57–CD1d tetramer, followed by iNKT17 cells and finally
iNKT1 cells. While the quantity of surface TCR available for
ligand interaction reflects this differential staining, it is possible
that it also mirrors the signaling capacity of the iNKT cell subsets,
with high TCR expressing cells capable of sustaining TCR
engagement for longer period of time that in turn affect the
kinase activity of Zap7029. A more direct measure of TCR signal
strength received by each subset, through direct staining of the
TCR-induced transcription factor Egr2, further reveals that
iNKT2 cells indeed receive stronger and/or more persistent TCR
signaling than iNKT17 and iNKT1 cells in vivo. This differential
Egr2 expression appears to be regulated at the transcriptional
level33.
As reported previously2, the frequency of Vβ usage varies
among iNKT cell subsets. Interestingly, Vβ usage within a given
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Fig. 7 Genome-wide chromatin landscapes of iNKT1 and iNKT2 subsets are affected by the SKG mutation. a, c Scatterplots of mean ATAC-seq counts per
peak comparing iNKT1 and iNKT2 subsets from BALB/c (a) or SKG (c) mice. b, d Boxplots of ATAC-seq counts per plots from the indicated samples
(labeled at the bottom) at common or differentially accessible regions from the comparison labeled above. Box indicates interquartile range with whiskers
± 1.5 times this range and outlier points. e Scatterplots of mean ATAC-seq counts per peak comparing iNKT1 from BALB/c vs SKG mice and iNKT2 subsets
from BALB/c vs SKG mice. f k-means clustered log2 fold-change from mean ATAC-seq signal for all differentially accessible regions compared to all
differentially accessible regions ini NKT1 and iNKT2 cells from BALB/c and SKG mice. The enrichment of known motifs within each cluster of differentially
accessible regions compared to all differentially accessible regions in iNKT1 and iNKT2 cells from BALB/c and SKG mice. All motifs with an enrichment log
p-value <−35 and found in 10% or more regions in at least one cluster are shown. g Mean ATAC-seq coverage at the Pdcd1 locus with a scale 0–1000 for
ATAC-Seq tracks. NFAT ChIP-seq coverage from CD8 T cells stimulated or not with PMA+ ionomycin for 1 h37 are also shown. h Flow cytometry analysis
of PD1 expression on thymic iNKT cell subsets from BALB/c (red) and SKG (blue) mice. i Mean ATAC-seq coverage at the Egr2 locus with a scale 0–1000
for ATAC-Seq tracks. j Mean ATAC-seq coverage at the Runx1 locus with a scale 0–1000 for ATAC-Seq tracks. For g, i, and j, ATAC peaks with differential
signals where BALB/c > SKG mice are highlighted in blue, while peaks with signals SKG > BALB/c mice in at least one subset are in red. k ATAC-Seq of
chromatin accessibility at the transcription start site of Klf2 in thymic iNKT1 and iNKT2 subsets from BALB/c and SKG mice
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these variations, discrete levels of Egr2 expression are observed in
each iNKT cell subset, irrespective of TCR expression levels.
These results support the idea that the actual Vβ-Vα usage (and
perhaps CDR3β sequence) expressed by each iNKT cell precursor
is responsible for the differential signaling observed, in good
agreement with recent findings showing that iNKT cell subset
development is affected by the biophysical properties of the
TCR–antigen–CD1d interaction47,48. That said, we do not
observe disparate TCR expression levels on the surface of stage 0
precursors. It is possible that small differences in TCR expression
levels on iNKT cell precursor cells exist, but cannot be resolved
with the current sensitivity of flow cytometry. Additionally, it is
also possible that, for equivalent levels of TCR expression, the
exact nature of each TCR dictates the signal strength received by
each precursor and that as a consequence of this signaling, each
precursor cell modulates its TCR surface level as the cell pro-
gresses through development49. In support of this hypothesis,
iNKT2 cells express the highest levels of TCR and also express the
highest levels of GATA350. While GATA3 is an autoactivator of
its own expression51, it also directly binds to several gene loci,
including Tcra, Tcrb, Cd3d, and Cd3g52, and controls surface TCR
expression level52,53. This might provide a positive regulatory
loop whereby cells that signal strongly would initially induce high
levels of GATA3, leading to increased surface expression of the
TCRs and increased avidity for their cognate ligands.
To test whether differential TCR signaling is required for the
proper development of iNKT cell subsets, we either reduced the
TCR repertoire diversity of iNKT cells through the use of TCRβ
transgenic mice or we reduced TCR signaling capacity of the
polyclonal repertoire through the use of mice containing hypo-
morph mutations in the proximal tyrosine kinase Zap70. In both
cases, we observe that limiting the strength of TCR signaling or
the diversity of the TCR repertoire, preferentially affects, in a cell-
intrinsic and genetic background independent manner, the
development of iNKT2 and iNKT17 cells, while iNKT1 cells are
less disturbed. These results are in agreement with the idea that
the stronger TCR signaling observed in the two former subsets is
indispensable to their proper development and cannot be
replaced by external cues. Transcriptomic analysis of the stage 0
iNKT population from wild-type and Zap70-mutant mice
demonstrates changes in expression of several transcripts coding
for genes that have previously been involved in
iNKT cells development, including Egr, Myc, Tcf7, and Klf2. For
example, stage 0 iNKT cells from SKG mice are enriched 4.5-fold
(padj < 0.07) in Klf2-encoding transcripts compared to their wild-
type counterpart. Interestingly, Klf2 deficiency results in
an increase in the proportion of iNKT2 cells2. Conversely, Myc-
encoding mRNA is increased in cells derived from the BALB/c
mice compared to SKG mice (2.1-fold, padj < 10−6). In the
absence of Myc, development of iNKT1 cells is blocked and the
remaining thymic iNKT cells have a phenotype reminiscent of
iNKT2 cells instead54, suggesting a role for Myc in the subset
differentiation of iNKT cells. These experiments argue that
reduced TCR signal strength during the positive selection of
iNKT cells changes the expression levels of several genes that
affect subsequent subset differentiation.
Surprisingly, we observe only small reductions in expression of
Egr2 (1.6 fold, padj < 0.5) and Egr1 mRNA (1.8 fold, padj < 0.0002)
in stage 0 iNKT cells from SKG mice compared to the BALB/c
mice. Analysis of Egr2 protein levels in stage 0 cells confirmes
these results. This is unexpected because both genes are well
known downstream targets of TCR signaling during thymic
selection55 and have been previously implicated in iNKT cell
development14–16. While the precise role of Egr1 remains unclear
and appears subtle in wild-type iNKT cells14,16, lack of Egr2
expression by contrast leads to severe deficiency early in iNKT
cell development15. Nevertheless, reduction of TCR signaling only
minimally affects the induction of Egr2 in early iNKT progeni-
tors. However, analysis of the subsequent stages of development
expose a severe loss of Egr2 expression in iNKT cell from SKG
mice compared to the levels observed in the same cells from
BALB/c mice. Thus, in the presence of reduced Zap70 activity, the
acute induction of Egr2 appears conserved but its prolonged
expression is not. This phenomenon can be mimicked in vitro
upon co-stimulation of pre-selection DP thymocytes with anti-
Ly108 and anti-CD3 mAbs. While very high levels of Egr2
expression can be achieved acutely in these conditions, more than
24 h of sustained stimulation is required for the highest Egr2-
expressing cells to express PLZF. Stimulation of SKG cells in the
same conditions does not sustain the levels of Egr2 expression
over time and few SKG DP thymocytes induce PLZF. Several
conclusions can be reached from these experiments. First,
expression of the PLZF protein can be induced in pre-selection
DP thymocytes in vitro and requires prolonged co-signaling
through the TCR and Ly108 molecules. These results support the
hypothesis that TCR signaling can instruct the development of
“innate” (as defined by PLZF expression) lymphocytes15,56,
including iNKT cells3, in contrast with other data32. Second, only
the highest Egr2-expressing cells are able to express the PLZF
protein, expanding upon previous results where gene expression
was examined by qPCR in entire cell populations17. Third, high
Egr2 expression levels are necessary but not sufficient to induces
PLZF, as it needs to be sustained for more than 24 h. We propose
that reduced TCR signaling in SKG mice affects the longevity of
Egr2 expression potentially through epigenetic mechanisms
involving downstream TCR signaling molecules. Because the
persistence of TCR signaling sustains cross talk with other
pathways that can further modulate T cell fate 57–60, other events
capable of modulating the strength and/or duration of signaling
in iNKT cell precursors could also affect subset specification.
Global epigenetic information is more stable than gene
expression profiles and propagates information over time during
development and differentiation61. Changes in chromatin acces-
sibility between iNKT1 and iNKT2 cells suggest lineage-specific
activity of regulatory elements. Several regions surrounding
iNKT1-expressed genes are only accessible in iNKT1 but not in
iNKT2 cells. Globally, these iNKT1-specific chromatin accessi-
bility regions are enriched for Runt, ETS and T-box binding
motifs, suggesting that transcription factors belonging to these
families might contribute to iNKT1 development by binding to
these differentially accessible regions. Importantly, few differences
in chromatin accessibility are observed between iNKT1 cells of
BALB/c or SKG mice, implying that reduced TCR signaling does
not appreciably affect the chromatin accessibility necessary to
establish the iNKT1 program. Conversely, we detected accessible
regulatory elements that are specific to iNKT2 cells. Generally,
iNKT2-specific regions are enriched for Tcf, Rorγt, Egr, and
NFAT-binding sites, indicating that commitment to the iNKT2
program might instead require binding of these transcription
factors to these regions. Remarkably, part of this iNKT2 signature
is affected by the SKG mutation with 30% of BALB/c iNKT2-
specific regions being inaccessible in SKG iNKT2 cells. These
regions are enriched for Egr and NFAT-binding sites, two tran-
scription factors with activity directly linked to TCR signaling.
These results suggest that efficient development of iNKT2 cells
requires higher activity of these two transcription factors for
binding to these regions. Altogether, our data point towards a
model of iNKT cell subset development where variable TCR
signaling might induce epigenetic changes at NFAT and Egr
binding sites that may have corresponding effects on gene
expression and differentiation. Whether these effects are due to
direct binding of these transcription factors and/or binding in
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collaboration with other transcription factors at these sites
remains to be determined.
Interestingly, the chromatin accessibility surrounding the Egr2
locus (and Runx1) is different between iNKT cell subsets, with
potential regulatory enhancer regions only accessible within
specific subsets. Furthermore, accessibility at several of these
enhancer regions is diminished and/or absent in SKG-derived
cells. Thus, modulation of accessibility to these enhancer regions
might have affected gene expression between subsets and between
BALB/c and SKG mice. Specific deletion of these enhancer
regions in vivo will be necessary to formally test this hypothesis.
However, because transcriptional regulation of PLZF expression
in iNKT cells has been linked to Egr215 and Runx138, reduced
expression of these two transcription factors in SKG cells would
be expected to affect the expression of PLZF and thereby devel-
opment of iNKT2/17 cells as well.
Our ATAC-seq analysis of iNKT2 cells in BALB/c and SKG
mice also reveals that expression of several genes coding for
regulators of the MAPK/Erk pathway might be affected by the
SKG mutation. These might be implicated in feedback circuitry
mechanisms essential in modulating the persistence of the sig-
nal62, as Egr2 induction downstream of TCR also requires the
Ras/MAPK/Erk pathway14. A stronger resurgence of Erk phos-
phorylation is observed in the stimulation of pre-selection DP
thymocytes in the presence of Ly108 co-stimulation17, suggesting
a potential role in regulating Erk oscillations over time and as a
consequence, possibly, the dynamics of epigenetic changes and
gene transcription in the cells63.
Finally, the Notch signaling pathway has an important role in
the differentiation of T cell effector subsets64. The chromatin
accessibility surrounding several genes involved in this pathway is
also affected by the reduced TCR signaling. While it is currently
unclear whether any of these potential enhancer regions modulate
gene activity, the results nevertheless suggest a potential cross talk
between TCR and Notch in further modulating signaling and the
differentiation of iNKT subsets in the thymus65. Future experi-
ments will explore these possibilities.
Methods
Mice. The SKG mice on the BALB/c background31, and YYAA mice on the
C57BL/6 background30 have been described previously. IL-4 reporter mice KN266
backcrossed to the BALB/c background and the YYAA mice were graciously
provided by Dr. Lee Reinhardt and Dr. Arthur Weiss, respectively. TCR transgenic
mice on the C57BL/6 background expressing the TCRβ chain from the DO11.10
hybridoma have been described previously67. These mice were crossed with BALB/
c mice to generate F1 expressing the transgene or not. Wild-type F1 littermates
were used as controls. C57BL/6, BALB/c, and CD45.1 congenic BALB/c mice
(CByJ.SJL(B6)-Ptprca/J) were purchased from Jackson Laboratories. All mice were
used between 8 and 10 weeks and were age-matched for each experiment. All mice
were raised in a specific pathogen-free environment at the Biology Resource Center
in National Jewish Health and the Office of Laboratory Animal Research at UCD.
All animal procedures were approved by the NJH (AS2780-10-16) and UCD (B-
64314(05)1E) Institutional Animal Care and Use Committees and were carried out
in accordance with the approved guidelines.
Thymocyte isolation and flow cytometry. Single-cell suspensions were prepared
from the thymus by manual disruption using syringe plunger. PBS57-CD1d1 tet-
ramer was obtained from the National Institutes of Health Tetramer Core Facility.
The complete list of surface antibodies used is as follows: Anti-CD5 (53-7.3), anti-
CD6 (BX222), anti-Ly6c (AL-21), anti-Vβ2 (B20.6), anti-Vβ7 (TR310), anti-Vβ8.1-
8.2 (MR5-2), anti-Vβ8.3 (1B3.3), anti-Egr2 (erongr2), anti-CD24 (M1/69), anti-
CD69 (H1.2F3). From BD Biosciences: anti-TCRβ (H57-597), anti-CD8α (53-6.7);
from BioLegend: anti-CD44 (IM7); anti-CD4 (RM4-5). Surface antibody staining
was done then cells were fixed and permeabilized using the FoxP3 buffer set
(eBioscience). Fixed and permeabilized cells were incubated with intracellular
antibodies including anti-PLZF (Mags.21F7; eBioscience), anti-Tbet (4B10; Bio-
Legend), and anti-Rorγt (Q31-378; BD Biosciences). Cells were analyzed on a BD
LSRFortessa (BD Biosciences) and data were processed with FlowJo software
(TreeStar).
Enrichment of CD1d-reactive thymocytes. Thymocytes were enriched for
PBS57–CD1d-reactive cells by incubating thymocyte cell suspensions with PE or
APC conjugated PBS57–CD1d tetramers for 45 min at 4 °C, then incubated with
anti-PE or anti-APC magnetic microbeads (Miltenyi Biotec) for 15 min at 4 °C,
followed by separation by using an autoMACS Pro Separator (Miltenyi Biotec)
according to manufacturer’s instructions. Cells were first stained for surface
markers and then intracellular stained for flow cytometric analysis.
Bone marrow chimeras. Bone marrow cells from wild-type congenic BALB/c mice
(CD45.1), BALB/c mice (CD45.2), and SKG (CD45.2) mice were harvested and
depleted of CD90-expressing cells using magnetic beads. Bone marrow cells from
wild-type CD45.1 mice were mixed at 1:1 ratio with either cells derived from wild-
type CD45.2 mice or SKG mice. Overall, 5 × 106 cells were injected intravenously
into lethally irradiated wild-type BALB/c (CD45.1 × CD45.2) recipient mice (1000
rads). Eight to ten weeks after reconstitution, chimeric mice were euthanized and
thymocytes were analyzed by flow cytometry.
In vitro stimulation of pre-selection DP thymocytes. Total thymocytes from
BALB/c and SKG mice were incubated with PE-labeled anti-CD127 (A7R34), anti-
CD3 (145-201), anti-CD25 (PC61.5), anti-CD69 (H1.2F3), and PBS57/CD1d tet-
ramers for 20 min at room temperature, washed and depleted using anti-PE
magnetic beads and autoMACS pro separator (Miltenyi Biotec). Overall, 5 × 105
pre-selection DP thymocytes (purity > 95%, verified by flow cytometry analysis for
each experiment) were then placed in wells of 96-well plates some of which had
been coated overnight with 1 µg/ml anti-CD3 (2C11) ± 5 µg/ml anti-Ly108 (13G3-
19D). At different time points post stimulation, cells were stained with surface
markers CD4 and CD8, fixed with the Foxp3 fixation/permeabilization kit and
stained intracellularly for Egr2 and PLZF. Each condition was tested in duplicate
for each independent experiment.
RNA-Seq. Stage 0 iNKT cells (PBS57–CD1d tetramer+, CD44−, CD24+, CD69+,
CD4lo/−, CD8−) were sorted from the pooled thymi of three BALB/c or SKG mice
(~1 × 103 cells were recovered) directly into Trizol buffer. Three independents
samples were generated for each genotype. RNA quality was evaluated with the
Bioanalyzer RNA pico kit (Agilent Technologies). Libraries were prepared from
polyA+ RNA using the Whole Transcriptome Amplification Sequencing Tech-
nology SEQR kit (Sigma-Aldrich). Briefly, purified RNA was reverse transcribed
using SuperScript II, Oligo dT30 VN primers, and template switching primers. A
preamplification step of eight PCR cycles was performed using the Kapa HiFi
Hotstart kit (Kapa Biosystems). The PCR product was purified using AMPureXP
beads (Beckman Coulter) and 1 ng was further used for library preparation using
the Nextera XT LibraryPrep kit (Illumina). Tagmented DNA was amplified with a
12-cycle PCR and again purified with AMPureXP beads. Library size distribution
and yield were evaluated using the Bioanalyzer high-sensitivity DNA kit. Libraries
were pooled at equimolar ratios and sequenced with the rapid run protocol on a
HiSeq. 2500 (Illumina) with 50-nt single end cycling.
RNA-Seq analysis. Reads were aligned using Hisat2 (v.2.1.0) with unstranded
default parameters and the primary GRCm38 genome assembly (downloaded 08/
26/2016). Reads overlapping exons were enumerated using featureCounts (subread
v.1.4.4) requiring a minimum mapping quality of 10 using GRCm38.85 ensembl
annotations (downloaded 08/26/2016). Counts were analyzed using the R package
DESeq2 and libraries were normalized using the default median ratio method.
Differentially expressed genes were required to pass a linear fold-change threshold
of 1.5 and a FDR threshold of 0.1.
ATAC-Seq. ATAC-seq was performed according to Buenrostro et al.68 with
50,000 sorted iNKT1 (CD27+, CD122+) or iNKT2 (CD27+, CD122−) cells.
iNKT17 cells were not analyzed due to the low number of cells recovered from the
SKG mice. Cells were lysed in 50 μl lysis buffer (10 mM TrisHCl, pH 7.4, 10 mM
NaCl, 3 mM MgCl2, 0.1% (v/v) Molecular biology-grade IGEPAL CA-630) to
extract nuclei. Nuclei were pelleted at 500×g. Nuclei were resuspended in 50 μl 1 ×
TD buffer containing 2.5 μl transposase (Nextera, Illumina). The transposase
reaction was conducted for 40 min at 37 °C. DNA was purified using MinElute
PCR Purification columns and kit (Qiagen) and barcoding were performed using
Illumina compatible index primers (IDTdna.com). PCR was conducted for 11–12
cycles. Library purification was performed with the MinElute PCR Purification Kit
(Qiagen) and library size selection was carried out using AMPureXP (Beckman
Coulter). Libraries were quantified and size distribution was assessed using the
Bioanalyzer High Sensitivity DNA Kit (Agilent). Paired-end sequencing was per-
formed on a HiSeq 2500 (Illumina) with 50 cycles for each read. Raw data from the
sequencer was demultiplexed and FASTQ files were generated using bcl2fastq
conversion software (Illumina).
ATAC-Seq analysis. Sequencing reads in FASTQ format were mapped to mouse
genome (mm10) using bowtie (version 1.0.0) with parameters “-p 8 -m 1 --best
--strata -X 2000 -S --fr --chunkmbs 1024.” Unmapped reads were processed with
trim_galore using parameters “--paired --nextera --length 37 --stringency 3
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–three_prime_clip_R1 1 --three_prime_clip_R2 1” before attempting to map again
using the above parameters. These two bam files were merged and processed to
remove reads mapping to the mitochondrial genome and duplicate reads (with
picard MarkDuplicates). For visualization, genomic coverage for individual repli-
cates were computed on 10 bp windows with MEDIPS using full fragments cap-
tured by ATAC-seq and used to generate average coverage with the Java Genomics
Toolkit for each group. To identify peaks, the bam files containing unique, non-
chrM reads were processed with samtools and awk using “‘{if(sqrt(/$9*/$9) < 100)
print0,}’” to identify nucleosome free DNA fragments <100 nt in length. These
subnucleosomal fragments were used to call peak summits for each replicate with
MACS2 using parameters “--nomodel -q 0.00001 --keep-dup all --call-summits.”
The summits for each peak from all replicates were expanded to regions with a
uniform size of 500 bp. These regions from all replicates were merged into one
global set of peaks and were filtered to remove peaks on the Y chromosome or
those that overlapped ENCODE blacklisted regions. The number of transposase
insertions within each region was computed for each replicate and these raw
ATAC-seq counts per peak for all replicates were normalized using voom. Pairwise
contrasts were performed with limma and differentially accessible regions were
filtered based on an FDR adjusted p-value of < 0.01 and an estimated fold-change
of at least 4. We computed the ATAC-seq density (number of transposase insertion
sites per kilobase) and accessible regions were defined as those with a mean of 3
normalized insertions per kilobase. We used HOMER to identify motifs for tran-
scription factor binding sites enriched in different groups of peaks.
Statistical analysis. Groups were compared with two-tailed Student’s t-tests or
one-way analysis of variance (ANOVA) with Prism 7 (Graphpad Software, Inc.).
*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
Data availability. Data that support the findings of this study have been deposited
in NCBI GEO with the accession code GSE110327 (RNA-Seq) and GSE111427
(ATAC-Seq).
Received: 25 April 2018 Accepted: 7 June 2018
References
1. Bendelac, A., Savage, P. B. & Teyton, L. The biology of NKT cells. Annu. Rev.
Immunol. 25, 297–336 (2007).
2. Lee, Y. J., Holzapfel, K. L., Zhu, J., Jameson, S. C. & Hogquist, K. A. Steady-
state production of IL-4 modulates immunity in mouse strains and is
determined by lineage diversity of iNKT cells. Nat. Immunol. 14, 1146–1154
(2013).
3. Gapin, L. Development of invariant natural killer T cells. Curr. Opin.
Immunol. 39, 68–74 (2016).
4. Berzins, S. P., McNab, F. W., Jones, C. M., Smyth, M. J. & Godfrey, D. I. Long-
term retention of mature NK1.1+ NKT cells in the thymus. J. Immunol. 176,
4059–4065 (2006).
5. Carty, S. A., Koretzky, G. A. & Jordan, M. S. Interleukin-4 regulates
eomesodermin in CD8+ T cell development and differentiation. PLoS ONE 9,
e106659 (2014).
6. Lee, A. et al. IL-4 induced innate CD8+ T cells control persistent viral
infection. PLoS Pathog. 11, e1005193 (2015).
7. Renkema, K. R. et al. IL-4 sensitivity shapes the peripheral CD8+ T cell pool
and response to infection. J. Exp. Med. 213, 1319–1329 (2016).
8. Kang, B. H. et al. PLZF+ innate T cells support the TGF-beta-dependent
generation of activated/memory-like regulatory T cells. Mol. Cells 39, 468–476
(2016).
9. White, A. J. et al. A type 2 cytokine axis for thymus emigration. J. Exp. Med.
214, 2205–2216 (2017).
10. Barik, S. et al. IL-4/IL-13 signaling inhibits the potential of early thymic
progenitors to commit to the T cell lineage. J. Immunol. 199, 2767–2776
(2017).
11. White, A. J. et al. An essential role for medullary thymic epithelial cells during
the intrathymic development of invariant NKT cells. J. Immunol. 192,
2659–2666 (2014).
12. Anderson, M. S. & Su, M. A. Aire and T cell development. Curr. Opin.
Immunol. 23, 198–206 (2011).
13. Aschenbrenner, K. et al. Selection of Foxp3+ regulatory T cells specific for self
antigen expressed and presented by Aire+ medullary thymic epithelial cells.
Nat. Immunol. 8, 351–358 (2007).
14. Hu, T., Gimferrer, I., Simmons, A., Wiest, D. & Alberola-Ila, J. The Ras/
MAPK pathway is required for generation of iNKT cells. PLoS ONE 6, e19890
(2011).
15. Seiler, M. P. et al. Elevated and sustained expression of the transcription
factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR
signaling. Nat. Immunol. 13, 264–271 (2012).
16. Lazarevic, V. et al. The gene encoding early growth response 2, a target of the
transcription factor NFAT, is required for the development and maturation of
natural killer T cells. Nat. Immunol. 10, 306–313 (2009).
17. Dutta, M. et al. A role for Ly108 in the induction of promyelocytic zinc finger
transcription factor in developing thymocytes. J. Immunol. 190, 2121–2128
(2013).
18. Baglaenko, Y. et al. Invariant NKT cell activation is potentiated by homotypic
trans-Ly108 interactions. J. Immunol. 198, 3949–3962 (2017).
19. Savage, A. K. et al. The transcription factor PLZF directs the effector program
of the NKT cell lineage. Immunity 29, 391–403 (2008).
20. Kovalovsky, D. et al. The BTB-zinc finger transcriptional regulator PLZF
controls the development of invariant natural killer T cell effector functions.
Nat. Immunol. 9, 1055–1064 (2008).
21. Mao, A. P. et al. Multiple layers of transcriptional regulation by PLZF in NKT-
cell development. Proc. Natl Acad. Sci. USA 113, 7602–7607 (2016).
22. Azzam, H. S. et al. CD5 expression is developmentally regulated by T cell
receptor (TCR) signals and TCR avidity. J. Exp. Med. 188, 2301–2311
(1998).
23. Mandl, J. N., Monteiro, J. P., Vrisekoop, N. & Germain, R. N. T cell-positive
selection uses self-ligand binding strength to optimize repertoire recognition
of foreign antigens. Immunity 38, 263–274 (2013).
24. Fulton, R. B. et al. The TCR’s sensitivity to self peptide-MHC dictates the
ability of naive CD8 T cells to respond to foreign antigens. Nat. Immunol. 15,
266–274 (2014).
25. Persaud, S. P., Parker, C. R., Lo, W.-L., Weber, K. S. & Allen, P. M. Intrinsic
CD4 + T cell sensitivity and response to a pathogen are set and sustained by
avidity for thymic and peripheral complexes of self peptide and MHC. Nat.
Immunol. 15, 266–274 (2014).
26. Orta-Mascaró, M. et al. CD6 modulates thymocyte selection and peripheral T
cell homeostasis. J. Exp. Med. 213, 1387–1397 (2016).
27. Martin, B. et al. Highly self-reactive naive CD4 T cells are prone to
differentiate into regulatory T cells. Nat. Commun. 4, 2209 (2013).
28. Moran, A. E. et al. T cell receptor signal strength in Treg and iNKT cell
development demonstrated by a novel fluorescent reporter mouse. J. Exp.
Med. 208, 1279–1289 (2011).
29. Klammt, C. et al. T cell receptor dwell times control the kinase activity of
Zap70. Nat. Immunol. 16, 961–969 (2015).
30. Hsu, L. Y., Tan, Y. X., Xiao, Z., Malissen, M. & Weiss, A. A hypomorphic allele
of ZAP-70 reveals a distinct thymic threshold for autoimmune disease versus
autoimmune reactivity. J. Exp. Med. 206, 2527–2541 (2009).
31. Sakaguchi, N. et al. Altered thymic T-cell selection due to a mutation of the
ZAP-70 gene causes autoimmune arthritis in mice. Nature 426, 454–460
(2003).
32. Zhang, S., Laouar, A., Denzin, L. K. & Sant’Angelo, D. B. Zbtb16 (PLZF) is
stably suppressed and not inducible in non-innate T cells via T cell receptor-
mediated signaling. Sci. Rep. 5, 12113 (2015).
33. Georgiev, H., Ravens, I., Benarafa, C., Förster, R. & Bernhardt, G. Distinct
gene expression patterns correlate with developmental and functional traits of
iNKT subsets. Nat. Commun. 7, 13116 (2016).
34. Engel, I. et al. Innate-like functions of natural killer T cell subsets result from
highly divergent gene programs. Nat. Immunol. 17, 728–739 (2016).
35. Lee, Y. J. et al. Lineage-specific effector signatures of invariant NKT cells are
shared amongst γδ T, innate lymphoid, and Th cells. J. Immunol. 197,
1460–1470 (2016).
36. Scott-Browne, J. P. et al. Dynamic changes in chromatin accessibility occur in
CD8(+) T cells responding to viral infection. Immunity 45, 1327–1340 (2016).
37. Martinez, G. J. et al. The transcription factor NFAT promotes exhaustion of
activated CD8+ T cells. Immunity 42, 265–278 (2015).
38. Mao, A. P., Ishizuka, I. E., Kasal, D. N., Mandal, M. & Bendelac, A. A shared
Runx1-bound Zbtb16 enhancer directs innate and innate-like lymphoid
lineage development. Nat. Commun. 8, 863 (2017).
39. McLean, C. Y. et al. GREAT improves functional interpretation of cis-
regulatory regions. Nat. Biotechnol. 28, 495–501 (2010).
40. Owens, D. M. & Keyse, S. M. Differential regulation of MAP kinase
signalling by dual-specificity protein phosphatases. Oncogene 26, 3203–3213
(2007).
41. Cabrita, M. A. & Christofori, G. Sprouty proteins, masterminds of receptor
tyrosine kinase signaling. Angiogenesis 11, 53–62 (2008).
42. Hayes, S. M., Li, L. & Love, P. E. TCR signal strength influences alphabeta/
gammadelta lineage fate. Immunity 22, 583–593 (2005).
43. Singer, A., Adoro, S. & Park, J. H. Lineage fate and intense debate: myths,
models and mechanisms of CD4- versus CD8-lineage choice. Nat. Rev.
Immunol. 8, 788–801 (2008).
44. Hogquist, K. A., Baldwin, T. A. & Jameson, S. C. Central tolerance: learning
self-control in the thymus. Nat. Rev. Immunol. 5, 772–782 (2005).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05026-6
12 NATURE COMMUNICATIONS |  (2018) 9:2650 | DOI: 10.1038/s41467-018-05026-6 | www.nature.com/naturecommunications
45. Hogquist, K. A. & Jameson, S. C. The self-obsession of T cells: how TCR
signaling thresholds affect fate ‘decisions’ and effector function. Nat.
Immunol. 15, 815–823 (2014).
46. Kain, L. et al. The identification of the endogenous ligands of natural killer
T cells reveals the presence of mammalian alpha-linked glycosylceramides.
Immunity 41, 543–554 (2014).
47. Cruz Tleugabulova, M. et al. Discrete TCR binding kinetics control invariant
NKT cell selection and central priming. J. Immunol. 197, 3959–3969 (2016).
48. Clancy-Thompson, E. et al. Monoclonal invariant NKT (iNKT) cell mice
reveal a role for both tissue of origin and the TCR in development of iNKT
functional subsets. J. Immunol. 199, 159–171 (2017).
49. Schrum, A. G., Turka, L. A. & Palmer, E. Surface T-cell antigen receptor
expression and availability for long-term antigenic signaling. Immunol. Rev.
196, 7–24 (2003).
50. Carr, T. et al. The transcription factor lymphoid enhancer factor 1 controls
invariant natural killer T cell expansion and Th2-type effector differentiation.
J. Exp. Med. 212, 793–807 (2015).
51. Ouyang, W. et al. Stat6-independent GATA-3 autoactivation directs IL-4-
independent Th2 development and commitment. Immunity 12, 27–37 (2000).
52. Wei, G. et al. Genome-wide analyses of transcription factor GATA3-mediated
gene regulation in distinct T cell types. Immunity 35, 299–311 (2011).
53. Ling, K. W. et al. GATA3 controls the expression of CD5 and the T cell
receptor during CD4 T cell lineage development. Eur. J. Immunol. 37,
1043–1052 (2007).
54. Mycko, M. P. et al. Selective requirement for c-Myc at an early stage of V
(alpha)14i NKT cell development. J. Immunol. 182, 4641–4648 (2009).
55. Shao, H., Kono, D. H., Chen, L. Y., Rubin, E. M. & Kaye, J. Induction of the
early growth response (Egr) family of transcription factors during thymic
selection. J. Exp. Med. 185, 731–744 (1997).
56. Kreslavsky, T. et al. TCR-inducible PLZF transcription factor required for
innate phenotype of a subset of gammadelta T cells with restricted TCR
diversity. Proc. Natl Acad. Sci. USA 106, 12453–12458 (2009).
57. Lee, I. H., Li, W. P., Hisert, K. B. & Ivashkiv, L. B. Inhibition of interleukin
2 signaling and signal transducer and activator of transcription (STAT)5
activation during T cell receptor-mediated feedback inhibition of T cell
expansion. J. Exp. Med. 190, 1263–1274 (1999).
58. Gomez-Rodriguez, J. et al. Itk-mediated integration of T cell receptor and
cytokine signaling regulates the balance between Th17 and regulatory T cells.
J. Exp. Med. 211, 529–543 (2014).
59. Gomez-Rodriguez, J. et al. Itk is required for Th9 differentiation via TCR-
mediated induction of IL-2 and IRF4. Nat. Commun. 7, 10857 (2016).
60. Yamane, H. & Paul, W. E. Early signaling events that underlie fate decisions of
naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol. Rev. 252,
12–23 (2013).
61. Lara-Astiaso, D. et al. Immunogenetics. Chromatin state dynamics during
blood formation. Science 345, 943–949 (2014).
62. Alam, R. & Gorska, M. M. Mitogen-activated protein kinase signalling and
ERK1/2 bistability in asthma. Clin. Exp. Allergy 41, 149–159 (2011).
63. Waters, K. M., Cummings, B. S., Shankaran, H., Scholpa, N. E. & Weber, T. J.
ERK oscillation-dependent gene expression patterns and deregulation by
stress response. Chem. Res. Toxicol. 27, 1496–1503 (2014).
64. Amsen, D., Helbig, C. & Backer, R. A. Notch in T cell differentiation: all things
considered. Trends Immunol. 36, 802–814 (2015).
65. Oh, S. J. et al. Notch 1 and Notch 2 synergistically regulate the differentiation
and function of invariant NKT cells. J. Leukoc. Biol. 98, 781–789 (2015).
66. Mohrs, K., Wakil, A. E., Killeen, N., Locksley, R. M. & Mohrs, M. A two-step
process for cytokine production revealed by IL-4 dual-reporter mice.
Immunity 23, 419–429 (2005).
67. Marrack, P. et al. The somatically generated portion of T cell receptor CDR3α
contributes to the MHC allele specificity of the T cell receptor. eLife 6, e30918
(2017).
68. Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J.
Transposition of native chromatin for fast and sensitive epigenomic profiling
of open chromatin, DNA-binding proteins and nucleosome position. Nat.
Methods 10, 1213–1218 (2013).
Acknowledgements
We thank Jennifer Matsuda, John Cambier, and Lee Reinhardt for their comments and
support; the National Jewish Health flow cytometry facility, the Mucosal and Vaccine
Research Colorado Flow Core, and the University of Colorado flow cytometry shared
resource facility for assistance with cell sorting; the Center for Genes, Environment, and
Health at National Jewish Health for ATAC sequencing; the Genomics and Microarray
core and the RNA Bioscience Initiative at the University of Colorado Denver for RNA-
Seq and the National Institutes of Health core facility for CD1d tetramers. This work was
supported by National Institutes of Health Grants AI121761 and AI124076 (to L.G.) and
AI18785 (to P.M.); the National Institutes of Health NIAID training grant (T32-
AI07405) award (to K.T.); The American Association for Immunologists Careers in
Immunology Fellowship (to L.G.); and The Cancer Center Support Grant P30CA046934.
Author contributions
L.G. wrote the manuscript and designed figures. L.G., K.T., S.H.K., and J.S.-B. designed
experiments. K.T., S.H.K., J.Z., R.B., C.H., A.L., and L.H. conducted experiments and
acquired data. L.G., K.T., S.H.K., J.-S.B., and K.R. analyzed and interpreted data. L.K.P.,
L.L.D., A.R., J.R.H., P.M., and B.O. provided invaluable reagents and insights. L.G.,
S.H.K., J.S.-B., and P.M. edited the manuscript. All authors approved the final
manuscript.
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
018-05026-6.
Competing interests: The authors declare no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2018
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05026-6 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:2650 | DOI: 10.1038/s41467-018-05026-6 | www.nature.com/naturecommunications 13
